Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

[DHEA: orthodox or alternative medicine?].

Cogan E.

Rev Med Brux. 2001 Sep;22(4):A381-6. Review. French.

PMID:
11680205
2.

Androgen therapy with dehydroepiandrosterone.

Buvat J.

World J Urol. 2003 Nov;21(5):346-55. Epub 2003 Oct 10. Review.

PMID:
14551720
3.

DHEA: the last elixir.

[No authors listed]

Prescrire Int. 2002 Aug;11(60):118-23.

PMID:
12199273
4.
5.

[Adrenopause and dehydroepiandrosterone: pharmacological therapy versus replacement therapy].

Römmler A.

Gynakol Geburtshilfliche Rundsch. 2003 Apr;43(2):79-90. German.

PMID:
12649580
6.

[Replacement and supplementation of DHEA--is it a wellness hormone?].

Brückel J.

MMW Fortschr Med. 2005 Feb 17;147(7):30-2. Review. German.

PMID:
18441581
7.

DHEA treatment: myth or reality?

Allolio B, Arlt W.

Trends Endocrinol Metab. 2002 Sep;13(7):288-94. Review.

PMID:
12163230
8.

The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.

von Mühlen D, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E.

Contemp Clin Trials. 2007 Feb;28(2):153-68. Epub 2006 May 6.

PMID:
16784898
9.

Uses of DHEA in aging and other disease states.

Johnson MD, Bebb RA, Sirrs SM.

Ageing Res Rev. 2002 Feb;1(1):29-41. Review.

PMID:
12039447
10.

[DHEA and aging].

Pitti-Ferrandi H.

Psychol Neuropsychiatr Vieil. 2003 Jun;1(2):111-9. Review. French.

PMID:
15683947
11.

Dehydroepiandrosterone therapy as female androgen replacement.

Saltzman E, Guay A.

Semin Reprod Med. 2006 Apr;24(2):97-105. Review.

PMID:
16633983
12.

[Focus on dehydroepiandrosterone (DHEA)].

Meyer P, Meier CA.

Rev Med Suisse. 2005 Feb 9;1(6):415-8. Review. French.

PMID:
15786645
13.

Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Legrain S, Girard L.

Drugs Aging. 2003;20(13):949-67. Review.

PMID:
14561100
14.

Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.

Nordmark G, Bengtsson C, Larsson A, Karlsson FA, Sturfelt G, Rönnblom L.

Autoimmunity. 2005 Nov;38(7):531-40.

PMID:
16373258
15.

Effects of dehydroepiandrosterone on bone mineral density: what implications for therapy?

Villareal DT.

Treat Endocrinol. 2002;1(6):349-57. Review.

PMID:
15832488
16.

The use of dehydroepiandrosterone therapy in clinical practice.

Cameron DR, Braunstein GD.

Treat Endocrinol. 2005;4(2):95-114. Review.

PMID:
15783247
18.

Therapeutic uses of dehydroepiandrosterone.

Hinson JP, Brooke A, Raven PW.

Curr Opin Investig Drugs. 2003 Oct;4(10):1205-8. Review.

PMID:
14649212
19.

A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.

Finckh A, Berner IC, Aubry-Rozier B, So AK.

J Rheumatol. 2005 Jul;32(7):1336-40.

PMID:
15996074
20.

Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status.

Christiansen JJ, Andersen NH, Sørensen KE, Pedersen EM, Bennett P, Andersen M, Christiansen JS, Jørgensen JO, Gravholt CH.

Clin Endocrinol (Oxf). 2007 Mar;66(3):426-33.

PMID:
17302879
Items per page

Supplemental Content

Write to the Help Desk